The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus by Alexander Sergeevich Ametov, Ekaterina Vladimirovna Karpova

Subjects: Get full text

Realisation of Remission of Diabetes Using Pharmacotherapy (DiaRem-1) by Anand Sudhayakumar, Durairaj Arjunan, Shobhit Bhansali, Harish Bhujade, Sanjay K. Bhadada, Sunita Malhotra, Rama Walia

Subjects: Get full text

Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications by Elena Valer'evna Biryukova

Subjects: Get full text

Vildagliptin: the first innovative DDP-4 inhibitor by Edvin Villkhauer

Subjects: Get full text

Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia by Lyudmila Viktorovna Nedosugova, Nina Alexandrovna Petunina, Karina Oganesovna Galstyan

Subjects: Get full text

CARDIOPRODUCTIVE EFFECTS OF EXXENATE AMID AND VILDAGLIPTIN INCRETIN MIMETICS IN DOXYRUBRICINE CARDIOMYOPATHY MODELING by A. P. TARASOVА, A. V. KHAVANSKY, A. S. TIMOKHINA, A. P. DOVGAN, D. A. KOSTINA, L. N. SERNOV

Subjects: Get full text

HPLC and HPTLC methods for simultaneous quantification of Metformin hydrochloride, Vildagliptin and Dapagliflozin propanediol with comparative evaluation by greenness and whiteness... by Krinal Barot, Vedika Thakkar, Devang Tandel, Gopi Patel, Rajesh Parmar, Kalpana Patel

Subjects: “…Vildagliptin…”
Get full text

Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study) by N. A. Demidov, M. B. Antsiferov, A. V. Zilov

Subjects: Get full text

Blue applicability grade index assessment and response surface modelling to synchronous determination of metformin hydrochloride, vildagliptin and dapagliflozin propanediol monohyd... by Pintu Prajapati, Krutika Patil, Dhrumi Naik, Veera Shakar Pulusu, Anzarul Haque, Mohd Abul Kalam, Shailesh Shah

Subjects: Get full text

A prospective, multicentre study evaluating safety and efficacy of a fixed dose combination of Remogliflozin etabonate, Vildagliptin, and Metformin in Indian patients with type 2 d... by Prabhat K Agarwal, Divendu Bhushan, Amit Bhate, Sunil Naik, Shailesh Adwani, J S Kushwaha, Sumit Bhushan, Abhishek Mane, Rujuta Gadkari, Sanjay Choudhari, Saiprasad Patil, Hanmant Barkate

Subjects: Get full text

Expert committee on introduction of incretin-based therapy in Russia: advance and failure by Editorial team Diabetes Mellitus

Subjects: Get full text

What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2... by Marina V. Shestakova, Mikhail B. Antsiferov, Alexander S. Ametov, Gagik R. Galstyan, Tatiana Y. Demidova, Alexey V. Zilov, Tatiana N. Markova, Nina A. Petunina, Natalya A. Chernikova, Minara S. Shamkhalova

Subjects: Get full text

Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy by Gagik Radikovich Galstyan, Svetlana Viktorovna Sergeeva

Subjects: Get full text

Perspective for the use of adamantane-type drugs for the treatment of cerebrovascular and cardiovascular diseases by D. A. Abaimov, A. A. Shabalina

Subjects: Get full text

Eco-Friendly electrochemical sensor for vildagliptin detection in human plasma: green approach using ZnO nanoparticles and graphene oxide by Bassant Samy, Mokhtar M. Mabrouk, Mohamed A. Abdel Hamid, Hytham M. Ahmed

Subjects: Get full text

The effects of vildagliptin on glycemic variability in patients with type 2 diabetes on premixed insulin therapy by Deyue Kong, Ziyang Shen, Lanlan Jiang, Xiaojing Xie, Rengna Yan, Ting Jing, Yun Hu, Jianhua Ma

Subjects: “…vildagliptin…”
Get full text

Vildagliptin: optimal control in type 2 diabetes mellitus treatment by Alexander Sergeevich Ametov

Subjects: Get full text

Perspectives of impaired glucose tolerance management in patients with metabolic syndrome by K. P. Ivanov, V. B. Mychka, Yu. V. Zhernakova, E. V. Tishina, S. N. Tolstov, V. P. Masenko, I. E. Chazova

Subjects: Get full text

First Russian DPP-4 inhibitor Gosogliptin comparing to Vildagliptin in type 2 diabetes mellitus patients by Karina Oganesovna Galstyan, Liudmila Viktorovna Nedosugova, Nina Alexandrovna Petunina, Julia Alexandrovna Trakhtenberg, Natalia Vadimovna Vostokova, Oksana Vladimirovna Karavaeva, Tatiana Evgenievna Chasovskaya

Subjects: Get full text

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus by Gagik Radikovich Galstyan

Subjects: Get full text